Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03314428
Other study ID # H17-01228
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date January 1, 2024
Est. completion date July 2025

Study information

Verified date November 2023
Source University of British Columbia
Contact Jean-Francois Esculier, PT, PhD
Phone 604-822-7948
Email jean-francois.esculier@ubc.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Tibiofemoral osteoarthritis (TFOA) is highly prevalent in older adults, and often causes symptoms and functional limitations. Physical activity is widely advocated in people with TFOA, and running is an easy and accessible activity that provides many benefits on general health. However, running induces high knee loads, which could potentially contribute to symptoms of runners with TFOA. Previous studies have suggested that running gait modifications can help in decreasing symptoms and knee loading in runners with knee conditions. Yet, no study has been conducted in runners with TFOA. This intervention study will investigate the effects of a 4-week running gait retraining program on symptoms and running biomechanics in runners with TFOA. We hypothesize that running modifications will decrease symptoms, improve function and reduce knee loading.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 18
Est. completion date July 2025
Est. primary completion date July 2025
Accepts healthy volunteers No
Gender Female
Age group 40 Years and older
Eligibility Inclusion Criteria: - TFOA of Grade 2 (mild) or 3 (moderate) on the Kellgren and Lawrence scale - report knee pain greater than or equal to 3/10 on a numerical pain rating scale (0-10) during most days of the previous month - run at least 10 km per week for a minimum of 6 months - declare being comfortable running on a treadmill for at least 30 minutes Exclusion Criteria: - history of traumatic knee injury - neurological or inflammatory arthritic condition - cardiovascular or cardiopulmonary disease preventing from safely performing moderate intensity running - presence of any lower limb condition affecting running (other than TFOA) - use of any oral or injected corticosteroids or viscosupplementation in the previous six months - regular use of non-steroidal anti-inflammatory drugs, analgesics or knee unloading bracing devices before, during or after running - non-English speaking

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Gait retraining
Over a 4-week period, runners will be asked to increase their step rate to reduce knee loading during running. Specifically, they will have to increase their preferred step rate by 10% during weekly laboratory running sessions as well as during habitual running training. In the laboratory, runners will be provided with live visual/auditory biofeedback on step rate and asked to target a specific value representing 110% or preferred step rate. During their individual running sessions, runners will be wearing a GPS-enabled watch that will provide feedback on live step rate, and they will be asked to maintain the same value as in the laboratory.

Locations

Country Name City State
Canada Robert H.N. Ho Research Centre Vancouver British Columbia

Sponsors (1)

Lead Sponsor Collaborator
University of British Columbia

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Other Compliance with gait retraining change Compliance with instructions on step rate will be measured through data collected with the provided watch and a logbook. We will also monitor weekly running distance during the course of the study. During Week 1, 2, 3 and 4 of the retraining program
Other Numeric pain rating scale for usual pain change Validated scale ranging from 0 (no pain) to 10 (worst imaginable pain), in which participants rate their level of pain during their usual daily activities over the previous week. Baseline, 2 weeks, 4 weeks, 2 months, 3 months, 4 months
Other Numeric pain rating scale for worst pain change Validated scale ranging from 0 (no pain) to 10 (worst imaginable pain), in which participants rate their worst level of pain over the previous week. Baseline, 2 weeks, 4 weeks, 2 months, 3 months, 4 months
Primary Knee Osteoarthritis Outcome Score (KOOS) change Validated questionnaire on symptoms and functional limitations related to knee osteoarthritis. The score is expressed in percentage (0-100), with 0 representing extreme knee problems and 100 representing no knee problems. Baseline, 2 weeks, 4 weeks, 2 months, 3 months, 4 months
Primary Peak knee adduction moment impulse change Validated surrogate measure of knee joint loading during movement. Expressed as Nm/kg*sec Baseline, 4 weeks, 4 months
Secondary Numerical pain rating scale for pain during running change Validated scale ranging from 0 (no pain) to 10 (worst imaginable pain), in which participants rate their worst level of pain during running over the previous week. Baseline, 2 weeks, 4 weeks, 2 months, 3 months, 4 months
Secondary Step rate change Number of steps taken during one minute of running. Baseline, 4 weeks, 4 months
Secondary Peak knee flexion moment impulse change Validated surrogate measure of knee joint loading during running. Expressed as Nm/kg*sec Baseline, 4 weeks, 4 months
See also
  Status Clinical Trial Phase
Recruiting NCT03895489 - Effectiveness of the Journey Total Knee Arthroplasty Versus Two Standard of Care Total Knee Arthroplasty Prostheses N/A
Completed NCT03660943 - A Clinical Study to Test Efficacy and Safety of Repeat Doses of CNTX-4975-05 in Patients With Osteoarthritis Knee Pain Phase 3
Completed NCT04531969 - Comparison of Outpatient and Inpatient Spa Therapy N/A
Completed NCT02848027 - Correlating the Osteoarthritic Knee Microenvironment to Clinical Outcome After Treatment With Regenexx®SD Treatment Phase 3
Completed NCT05160246 - The Instant Effect of Kinesiology Taping in Patients With Knee OA N/A
Recruiting NCT06080763 - Biomechanics and Clinical Outcomes in Responders and Non-Responders
Completed NCT03643588 - The Comparison of HYAJOINT Plus and Hyalgan Hyaluronan Supplement for Knee Osteoarthritis Pain N/A
Active, not recruiting NCT05100225 - Efficacy and Safety Trial of PTP-001 (MOTYS) for Symptomatic Knee Osteoarthritis Phase 2
Active, not recruiting NCT04061733 - New Hydroxyethyl Cellulose Hydrogel for the Treatment of the Pain of Knee Arthrosis N/A
Completed NCT04051489 - A Novel Smartphone Application for "Smart" Knee Osteoarthritis Trials
Recruiting NCT05546541 - Epidemiology and Nutrition
Recruiting NCT05447767 - Prediction AlgoriThm for regeneraTive Medicine Approach in knEe OA: New Decision-making Process Based on Patient pRofiliNg Phase 2
Not yet recruiting NCT04448106 - Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis Phase 2
Not yet recruiting NCT03225911 - Effect of a Lateral Wedge Insole and Simple Knee Sleeve in Individuals With Knee Osteoarthritis N/A
Completed NCT05070871 - A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women N/A
Completed NCT05703087 - Positive Cueing in Knee Arthroplasty. N/A
Not yet recruiting NCT06042426 - Effects of Perioperative Intravenous Dexamethasone in Clinical Outcomes After Total Knee Arthroplasty in a Hispanic Population Phase 4
Not yet recruiting NCT02865174 - Topical Tranexamic Acid and Floseal® in Total Knee Arthroplasty Phase 4
Completed NCT03037489 - A Study to Evaluate Safety and Tolerability of MIV-711 in Osteoarthritis Patients Phase 2
Terminated NCT02615522 - Prospective Post Market Clinical Follow-Up of the Primary Knee Endoprosthesis BPK-S Integration